.png){kind=logo}
GC Asia
Sanofi latest IG borrower to reprice loan
French pharmaceutical company Sanofi, rated A1/AA, has amended a €7bn credit line, stretching the tenor out by a year and cutting the pricing.
The loan, signed in 2011, was due to mature in 2017, but will now be repaid a year later. The new deal also has two one year extension options.
"This facility has neither rating grid nor financial covenants," said a Sanofi spokesperson by email.
The spokesperson added: "In addition to ...Already a subscriber? Login
-
Latest news from Securitization
-
SAIC-GMAC preps rapid auto ABS return
07.00 AM -
Trio of banks arrange a $700m CLO for GoldenTree
25 Jan 2021 -
Fitch stabilizes CLO ratings on new Covid scenario
25 Jan 2021 -
New CFPB leader may have 'deleterious' impact on ABS market
25 Jan 2021 -
Post-Brexit clarity lets European accounts dive into UK RMBS
25 Jan 2021
-
-
Latest news from Securitization
-
SAIC-GMAC preps rapid auto ABS return
07.00 AM -
Trio of banks arrange a $700m CLO for GoldenTree
25 Jan 2021 -
Fitch stabilizes CLO ratings on new Covid scenario
25 Jan 2021 -
New CFPB leader may have 'deleterious' impact on ABS market
25 Jan 2021 -
Post-Brexit clarity lets European accounts dive into UK RMBS
25 Jan 2021
-
